Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Bevacizumab in Treating Patients With Recurrent or Progressive Glioma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
- Status
- TERMINATED
- Phase
- PHASE4
Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
- Status
- TERMINATED
- Phase
- PHASE3
Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema
- Status
- UNKNOWN
- Phase
- PHASE1